These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 12429512)

  • 1. Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity.
    Osorio FA; Galeota JA; Nelson E; Brodersen B; Doster A; Wills R; Zuckermann F; Laegreid WW
    Virology; 2002 Oct; 302(1):9-20. PubMed ID: 12429512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent.
    Lopez OJ; Oliveira MF; Garcia EA; Kwon BJ; Doster A; Osorio FA
    Clin Vaccine Immunol; 2007 Mar; 14(3):269-75. PubMed ID: 17215336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porcine reproductive and respiratory syndrome virus neutralizing antibodies provide in vivo cross-protection to PRRSV1 and PRRSV2 viral challenge.
    Robinson SR; Rahe MC; Gray DK; Martins KV; Murtaugh MP
    Virus Res; 2018 Mar; 248():13-23. PubMed ID: 29408442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-protection of a modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine against a heterologous PRRSV-1 challenge in late-term pregnancy gilts.
    Jeong J; Park C; Oh T; Park KH; Yang S; Kang I; Park SJ; Chae C
    Vet Microbiol; 2018 Sep; 223():119-125. PubMed ID: 30173737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of homologous porcine reproductive and respiratory syndrome virus immunity in pregnant swine.
    Lager KM; Mengeling WL; Brockmeier SL
    Vet Microbiol; 1997 Nov; 58(2-4):127-33. PubMed ID: 9453124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of protective immunity in gilts inoculated with the NADC-8 isolate of porcine reproductive and respiratory syndrome virus (PRRSV) and challenge-exposed with an antigenically distinct PRRSV isolate.
    Lager KM; Mengeling WL; Brockmeier SL
    Am J Vet Res; 1999 Aug; 60(8):1022-7. PubMed ID: 10451216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge.
    Jeong J; Kang I; Kim S; Park SJ; Park KH; Oh T; Yang S; Chae C
    Transbound Emerg Dis; 2018 Oct; 65(5):1227-1234. PubMed ID: 29536637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate and adaptive immunity against Porcine Reproductive and Respiratory Syndrome Virus.
    Loving CL; Osorio FA; Murtaugh MP; Zuckermann FA
    Vet Immunol Immunopathol; 2015 Sep; 167(1-2):1-14. PubMed ID: 26209116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
    Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
    Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
    Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
    Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus.
    Jiang Y; Fang L; Xiao S; Zhang H; Pan Y; Luo R; Li B; Chen H
    Vaccine; 2007 Jan; 25(3):547-60. PubMed ID: 16920232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of commercial genotype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against field isolate of genotype 2 PRRSV.
    Ko SS; Seo SW; Sunwoo SY; Yoo SJ; Kim MH; Lyoo YS
    Vet Immunol Immunopathol; 2016 Apr; 172():43-9. PubMed ID: 27032502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homologous challenge of porcine reproductive and respiratory syndrome virus immunity in pregnant swine.
    Lager KM; Mengeling WL; Brockmeier SL
    Vet Microbiol; 1997 Nov; 58(2-4):113-25. PubMed ID: 9453123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of neutralizing antibodies in PRRSV protective immunity.
    Lopez OJ; Osorio FA
    Vet Immunol Immunopathol; 2004 Dec; 102(3):155-63. PubMed ID: 15507302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic B- and T-cell epitope peptides of porcine reproductive and respiratory syndrome virus with Gp96 as adjuvant induced humoral and cell-mediated immunity.
    Chen C; Li J; Bi Y; Yang L; Meng S; Zhou Y; Jia X; Meng S; Sun L; Liu W
    Vaccine; 2013 Apr; 31(14):1838-47. PubMed ID: 23395588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal immunization of pigs with porcine reproductive and respiratory syndrome virus-like particles plus 2', 3'-cGAMP VacciGrade™ adjuvant exacerbates viremia after virus challenge.
    Van Noort A; Nelsen A; Pillatzki AE; Diel DG; Li F; Nelson E; Wang X
    Virol J; 2017 Apr; 14(1):76. PubMed ID: 28403874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a broadly protective modified-live virus vaccine candidate against porcine reproductive and respiratory syndrome virus.
    Sun H; Workman A; Osorio FA; Steffen D; Vu HLX
    Vaccine; 2018 Jan; 36(1):66-73. PubMed ID: 29174314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virological and immunological responses to porcine reproductive and respiratory syndrome virus in a large population of gilts.
    Batista L; Pijoan C; Dee S; Olin M; Molitor T; Joo HS; Xiao Z; Murtaugh M
    Can J Vet Res; 2004 Oct; 68(4):267-73. PubMed ID: 15581221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
    Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
    Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection.
    Cao QM; Ni YY; Cao D; Tian D; Yugo DM; Heffron CL; Overend C; Subramaniam S; Rogers AJ; Catanzaro N; LeRoith T; Roberts PC; Meng XJ
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.